Literature DB >> 3533919

Structural differences between liver- and muscle-derived insulin receptors in rats.

C F Burant, M K Treutelaar, N E Block, M G Buse.   

Abstract

The structure of insulin receptors, solubilized from rat skeletal muscle and liver, was studied. The alpha subunit was identified by specific cross-linking to A14 125I-insulin with disuccinimidyl suberate. Muscle- and liver-derived alpha subunits migrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with a Mr of 131,000 and 135,000, respectively. There was no significant difference in insulin binding affinity. Treatment of cross-linked, immunoprecipitated receptors with either neuraminidase or endoglycosidase H decreased the Mr of muscle- and liver-derived alpha subunits but did not affect the difference in Mr. Autophosphorylated beta subunits migrated with a Mr of 98,000 for muscle and 101,000 for liver. After partial V8 digestion of autophosphorylated, immunoprecipitated receptors the major phosphopeptide fragment migrated on SDS-PAGE at Mr 57,000 from muscle and 60,000 from liver. Glycosidase digestion of autophosphorylated receptors suggested that Mr heterogeneity was due in part to differences in the sialic acid content of beta subunits. Muscle and liver are the major target organs of insulin; the apparent heterogeneity of insulin receptor structure may be relevant to tissue-specific differences in insulin action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein.

Authors:  G Sesti; A N Tullio; R D'Alfonso; M L Napolitano; M A Marini; P Borboni; R Longhi; L Albonici; A Fusco; A M Aglianò
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

3.  Glucose metabolism during the early "flow phase" after burn injury.

Authors:  Hongzhi Xu; Yong-Ming Yu; Harry Ma; Edward A Carter; Shawn Fagan; Ronald G Tompkins; Alan J Fischman
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

4.  2'-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway.

Authors:  Wang Yinghao; Guan Qiaoli; Liu Guanfu; Wu Xiaoyun; Wang Xuanjun; Sheng Jun
Journal:  J Diabetes Res       Date:  2022-04-23       Impact factor: 4.061

5.  Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms.

Authors:  G Kotzke; M Schütt; U Missler; D E Moller; H L Fehm; H H Klein
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

6.  Insulin-mimetic actions of phorbol ester in cultured adult rat hepatocytes. Lack of phorbol-ester-elicited inhibition of the insulin signal.

Authors:  A Quentmeier; H Daneschmand; H Klein; K Unthan-Fechner; I Probst
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

7.  Demonstration of a relatively hepatoselective effect of covalent insulin dimers on glucose metabolism in dogs.

Authors:  F Shojaee-Moradie; N C Jackson; M Boroujerdi; D Brandenburg; P H Sönksen; R H Jones
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

8.  Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.

Authors:  A A Alzaid; S F Dinneen; D J Turk; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.

Authors:  H Hartmann; K Oberhaus; R Spahr; D Brandenburg; W Creutzfeldt; I Probst
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.